Tuesday, May 21, 2013 Last update: 6:42 AM
Company Tech News as it Breaks
Trade Events
KineMed, Inc.
News articles for KineMed, Inc.:
Tuesday, May 21, 2013
- KineMed Announces an Agreement With MedImmune to Study Protein Dynamics Related to Neurodegenerative DiseasesKineMed Inc. (www.kinemed.com) today announced an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to study how a monoclonal ... read more
Wednesday, March 13, 2013
- Connecting Biomarkers with Clinical Symptoms and Neuronal Dysfunction in Brain DisordersKineMed (www.kinemed.com) announced today that Dr. Patrizia Fanara, Vice President, Neuroscience at KineMed, Inc., will present recent progress in the development of ... read more
Thursday, February 21, 2013
- Huntington’s Disease Therapeutic and Companion Biomarker Collaboration Forged by KineMed, Isis Pharmaceuticals, and CHDI FoundationKineMed, Inc., Isis Pharmaceuticals Inc. (NASDAQ: ISIS), and CHDI Foundation, Inc., announced today that they are collaborating to utilize KineMed’s translational biomarker platform with Isis’ antisense ... read more
Tuesday, February 5, 2013
- Commercializing Biomarkers of Disease-Modification for Decision Making in Drug Development, Diagnosis and Therapeutic MonitoringKineMed, Inc. (www.kinemed.com) announced today that David Fineman, President and CEO of KineMed, Inc. will present at the 15th Annual BIO CEO & Investor Conference taking ... read more
Thursday, January 3, 2013
- The First Functionally Interpretable Systems Biology Platform for Personalized Medicine and Drug DevelopmentKineMed, Inc. (www.kinemed.com) announced today that David Fineman, KineMed’s CEO will present at the 2013 Biotech Showcase Conference on Monday, January 7th at 2:00 p.m. on ... read more